Sichenzia Ross Ference LLP Represents Aegis Capital Corp in $15 Million Registered Direct Offering of Molecular Data Inc.
Press Release – New York, NY – September 22, 2021 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as exclusive placement agent in a $15 million registered direct offering of Molecular Data Inc. (NASDAQ: “MKD”) a leading technology-driven platform in China’s chemical industry. The registered direct offering consisted of the purchase and sale of common units, consisting of one American Depositary Share, each representing three of its Class A ordinary shares, and one warrant to purchase one ADS, and pre-funded units consisting of one pre-funded warrant to purchase one ADS and one warrant to purchase one ADS. The gross proceeds of the offering were approximately $15 million.
The securities were offered by Molecular Data Inc. pursuant to a “shelf” registration statement on Form F-3 (File No. 333-256451) previously filed with the Securities and Exchange Commission.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, Huan Lou and Jeff Cahlon and associate Matthew Siracusa.
- Sichenzia Ross Ference LLP Represents EF Hutton in $8.4 Million Simultaneous Registered Direct Offering and Private Placement of Securities of Nemaura Medical, Inc. - February 3, 2023
- Sichenzia Ross Ference LLP Represents Verb Technology Company, Inc. in $7.2 Million Underwritten Public Offering of Common Stock - January 26, 2023
- Sichenzia Ross Ference LLP Represents Jupiter Wellness, Inc. in $4.1 Million Registered Direct Offering and Concurrent Private Placement of Warrants - January 24, 2023